Reports link bone-building drugs to rare leg fracture

07/15/2008 |

Case studies on a rare type of leg fracture after little or no trauma among people who took bisphosphonates for five years or more have raised concerns that long-term use of the bone-building drugs may actually weaken bones. Merck & Co.'s Fosamax was cited in the reports, and the company said it will investigate whether the fracture pattern can be found commonly in people who take bone medicines.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA